Last Price
4.38
Today's Change
-0.15 (3.31%)
Day's Change
4.37 - 4.59
Trading Volume
257,317
Profile
ZURA
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Robert Lisicki Mr. Robert Lisicki
Full Time Employees: 14 14
IPO Date: 2023-03-21 2023-03-21
CIK: 0001855644 0001855644
ISIN: KYG9TY5A1016 KYG9TY5A1016
Beta: 0.14 0.14
Last Dividend: 0.00 0.00
Dcf Diff: 1.70 1.70
Dcf: 3.02 3.02
Description
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
2
CEO Morning Brief
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
3
CEO Morning Brief
4
CEO Morning Brief
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
